MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics, Inc. (TRDA)

|||

Balance Sheets Overview

Current Ratio
1390.32%
Quick Ratio
1390.32%
Cash Ratio
398.25%
Debt to Asset Ratio
19.27%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Right-of-use assets, operating l...
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paidin capital
    • Accumulated deficit
    • Operating lease obligations, net...
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
76,444
90,394
93,286
72,482
Marketable securities
178,415
205,304
233,552
281,530
Restricted cash, current portion
0
658
-
-
Collaboration receivable
787
1,177
1,196
1,180
Prepaid expenses and other current assets
11,226
8,719
10,223
13,954
Total current assets
266,872
306,252
338,257
369,146
Property and equipment, net
6,506
7,313
8,406
9,807
Restricted cash
3,292
3,292
3,950
3,950
Right-of-use assets, operating leases
58,758
60,451
62,122
65,681
Other non-current assets
90
70
163
199
Total assets
335,518
377,378
412,898
448,783
Accounts payable
2,930
2,289
3,166
1,857
Accrued expenses and other current liabilities
11,730
17,682
15,532
11,795
Income taxes payable
-
0
620
0
Operating lease obligations, current portion
4,281
4,138
4,350
5,462
Deferred revenue, current portion
254
342
351
689
Total current liabilities
19,195
24,451
24,019
19,803
Operating lease obligations, net of current portion
45,469
46,794
48,050
49,281
Deferred revenue, net of current portion
-
0
113
194
Total liabilities
64,664
71,245
72,182
69,278
Common stock, par value 0.0001 150,000,000 shares authorized 38,820,616 shares issued and outstanding as of march31, 2026 and 38,284,221 shares issued and outstanding as of december31, 2025
4
4
4
4
Additional paidin capital
583,415
578,571
574,021
568,897
Accumulated other comprehensive income
246
652
621
400
Accumulated deficit
-312,811
-273,094
-233,930
-189,796
Total stockholders equity
270,854
306,133
340,716
379,505
Total liabilities and stockholders equity
335,518
377,378
412,898
448,783
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$178,415K Cash and cashequivalents$76,444K Prepaid expenses andother current assets$11,226K Collaboration receivable$787K Total current assets$266,872K Right-of-use assets,operating leases$58,758K Property and equipment,net$6,506K Restricted cash$3,292K Other non-currentassets$90K Total assets$335,518K Total liabilities andstockholders equity$335,518K Total stockholdersequity$270,854K Total liabilities$64,664K Accumulated deficit-$312,811K Additional paidin capital$583,415K Operating leaseobligations, net of current...$45,469K Total currentliabilities$19,195K Accumulated othercomprehensive income$246K Common stock, par value0.0001 150,000,000...$4K Accrued expenses andother current...$11,730K Operating leaseobligations, current portion$4,281K Accounts payable$2,930K Deferred revenue,current portion$254K